Skip to content

Study · Not a test of the peptide alone · 1990

4 results

[Use of thymic peptide thymalin in the complex treatment of therapy-resistant schizophrenia].

Govorin NV, Stupina OP

Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952)1 Jan 1990

PMID2163147 (opens in a new tab)PepBankPUB-02163147
Publisher pageAsk about this study
Jump to 4 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study4

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone4

In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymalin.

  1. 01HumanNot a test of Thymalin aloneNon-randomized trialEfficacy outcome

    In therapy-resistant schizophrenia, thymaline with psychotropic drugs eliminated or ameliorated psychic disorders.

    In plain wordsIn patients with therapy-resistant schizophrenia, the thymaline and psychotropic drug regimen eliminated or reduced psychiatric disorders.

    Peptide
    Thymalin
    Outcome
    DecreasePsychic disorders
    Study

    n = 36

    Outcome group
    Psychiatric symptoms · Mental health and mood

    Source sentences

    Summary
    Such a policy favoured considerable enhancement of the treatment efficacy which manifested itself by the elimination or amelioration of psychic disorders, appreciable activation of patients and reduction of neuroleptic complications.
    1 context sentence
    Summary · context
    The thymic peptide thymaline combined with psychotropic drugs was used in the treatment of 36 therapeutically resistant patients with pronounced immune abnormalities.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

  2. 02HumanNot a test of Thymalin aloneNon-randomized trialEfficacy outcome

    In therapy-resistant schizophrenia, thymaline with psychotropic drugs appreciably activated patients.

    In plain wordsIn patients with therapy-resistant schizophrenia, the thymaline and psychotropic drug regimen increased patient activity.

    Peptide
    Thymalin
    Outcome
    IncreasePatient activation
    Study

    n = 36

    Outcome group
    Psychiatric symptoms · Mental health and mood

    Source sentences

    Summary
    Such a policy favoured considerable enhancement of the treatment efficacy which manifested itself by the elimination or amelioration of psychic disorders, appreciable activation of patients and reduction of neuroleptic complications.
    1 context sentence
    Summary · context
    The thymic peptide thymaline combined with psychotropic drugs was used in the treatment of 36 therapeutically resistant patients with pronounced immune abnormalities.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

  3. 03HumanNot a test of Thymalin aloneNon-randomized trialSafety outcome

    In therapy-resistant schizophrenia, thymaline with psychotropic drugs reduced neuroleptic complications.

    In plain wordsIn patients with therapy-resistant schizophrenia, the thymaline and psychotropic drug regimen reduced complications from neuroleptic drugs.

    Peptide
    Thymalin
    Outcome
    DecreaseNeuroleptic complications
    Study

    n = 36

    Outcome group
    Adverse events · Mental health and mood

    Source sentences

    Summary
    Such a policy favoured considerable enhancement of the treatment efficacy which manifested itself by the elimination or amelioration of psychic disorders, appreciable activation of patients and reduction of neuroleptic complications.
    1 context sentence
    Summary · context
    The thymic peptide thymaline combined with psychotropic drugs was used in the treatment of 36 therapeutically resistant patients with pronounced immune abnormalities.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

  4. 04HumanNot a test of Thymalin aloneNon-randomized trialOther

    In patients receiving thymaline with psychotropic drugs, clinical improvement correlated with immune normalization, especially with secondary pharmacogenic or pathological-ground resistance.

    In plain wordsIn patients receiving the thymaline and psychotropic drug regimen, clinical improvement was linked to immune normalization, especially in certain resistance types.

    Peptide
    Thymalin
    Outcome
    Not applicableClinical improvement and immune normalization correlation
    Study

    n = 36

    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    The positive dynamics in the patients' status always correlated with the normalization of immune abnormalities, with this being seen to a greater degree in cases of the secondary "pharmacogenic" resistance and resistance because of the "pathological ground".
    1 context sentence
    Summary · context
    The thymic peptide thymaline combined with psychotropic drugs was used in the treatment of 36 therapeutically resistant patients with pronounced immune abnormalities.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.